EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseVergleichsstudie

Progression-free survival prediction and comparative metastasis detection accuracy of 18F-FES PET/CT for ER-Positive breast cancer: Systematic review, meta-analyses and meta-regressions

Matheus Henrique Leite E Silva iD, Pablo Vinícius Nicoletti Ramos iD, Daniel Simões Reis Dos Santos iD, Matheus Aleixo Barbosa da Silva iD, Fernanda Yamazaki Amaral iD, Marcelo Mamede iD

European Journal of Nuclear Medicine and Molecular Imaging · 2026-03 · 53 (4) · 2815-2829

DOI: 10.1007/s00259-025-07640-1 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 04.11.2025. Verfasst von Matheus Henrique Leite E Silva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Breast Neoplasms, Estradiol, Receptors, Estrogen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The role of 18F-fluoroestradiol (18F-FES) PET/CT has been investigated in breast cancer recurrence identification and noninvasive hormone receptor profiling. The detection of distant metastasis, however, lacks high quality evidence comparing FES to standard imaging protocols. Additionally, if 18F-FES PET/CT is to become one of the first-line exams in ER positive breast cancer patients, obtaining its maximum utility will be beneficial and this includes prognosis prediction. Here, we address these issues by analyzing literature on diagnostic accuracy comparisons and reconstructing progression-free survival data to investigate the ideal PET parameter for predicting survival. METHODS: A systematic review was conducted on PubMed, Scopus and Embase to identify studies assessing survival or diagnostic outcomes on breast cancer patients undergoing 18F-FES PET/CT for metastasis detection. Random-effects inverse variance meta-analyses were conducted for summarizing hazard ratios, sensitivity, specificity and likelihood ratios. Meta-regressions were conducted to compare 18F-FES PET/CT and 18F-FDG PET/CT; and to evaluate the impact of clinical covariates on the survival prediction potential of 18F-FES PET/CT. Risk of bias was assessed using the QUADAS-2 and QUADAS-C tools, for diagnostic studies; and the Evidence Project risk of bias tool for the survival trials. RESULTS: 19 papers were included. 10 studies had survival outcomes, and 9 had diagnostic endpoints. Overall, patients with higher 18F-FES SUVmax, complete lesion concordance or no complete lesion discordance had significantly longer PFS (HR:0.29 [0.16-0.54]). Stratification by complete lesion concordance had numerically longer PFS than stratification by 18F-FES SUVmax. Out of the 9 metastasis detection studies, 3 were pooled in the bivariate model, resulting in overall estimates for 18F-FES PET/CT and 18F-FDG PET/CT or CT, respectively, of 87.9% [82.6-91.7%] and 83.4% [80-87%] for sensitivity; and 97.1% [85.4-99.5%] and 45.5% [4.8-93.2%] for specificity. For confirmation, 6 studies had their sensitivities meta-analyzed in a univariate approach, with similar results. A bivariate meta-regression showed a significant difference in sensitivity between modalities. CONCLUSION: Patients with higher 18F-FES SUVmax or full lesion concordance on 18F-FES/FDG PET/CT have significantly longer PFS. Lesion concordance approaches were associated with longer PFS. 18F-FES PET/CT has slightly higher sensitivity than 18F-FDG PET/CT for metastasis detection in the ER+/HER2- metastatic breast cancer setting. Cost-benefit analysis will be essential in the development of guidelines to integrate its clinical applicability, on a case-by-case basis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyBreast NeoplasmsEstradiolReceptors, EstrogenHumansFemaleNeoplasm MetastasisProgression-Free Survival

Stichwörter der Autor:innen

16-FluoroestradiolBreast cancerMeta-AnalysisMeta-RegressionSurvival analysis

Substanzen

16-fluoroestradiolEstradiolReceptors, Estrogen

Autor:innen und Institutionen

  • Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Anatomy and Imaging Department, Faculty of Medicine, Federal University of Minas Gerais, Av. Prof. Alfredo Balena, 190/Room 175 - Centro, Belo Horizonte, Minas Gerais, Brazil. mamede.mm@gmail.com.

ORCID-Profile: Matheus Henrique Leite E Silva, Pablo Vinícius Nicoletti Ramos, Daniel Simões Reis Dos Santos, Matheus Aleixo Barbosa da Silva, Fernanda Yamazaki Amaral, Marcelo Mamede

Zitieren

APA

Leite E Silva, M. H., Ramos, P. V. N., Reis Dos Santos, D. S., da Silva, M. A. B., Amaral, F. Y., & Mamede, M. (2026). Progression-free survival prediction and comparative metastasis detection accuracy of 18F-FES PET/CT for ER-Positive breast cancer: Systematic review, meta-analyses and meta-regressions. European Journal of Nuclear Medicine and Molecular Imaging, 53(4), 2815-2829. https://doi.org/10.1007/s00259-025-07640-1

Vancouver

Leite E Silva MH, Ramos PVN, Reis Dos Santos DS, da Silva MAB, Amaral FY, Mamede M. Progression-free survival prediction and comparative metastasis detection accuracy of 18F-FES PET/CT for ER-Positive breast cancer: Systematic review, meta-analyses and meta-regressions. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(4):2815-2829. doi:10.1007/s00259-025-07640-1

BibTeX
@article{LeiteESilva2026,
  author = {Leite E Silva, Matheus Henrique and Ramos, Pablo Vinícius Nicoletti and Reis Dos Santos, Daniel Simões and da Silva, Matheus Aleixo Barbosa and Amaral, Fernanda Yamazaki and Mamede, Marcelo},
  title = {Progression-free survival prediction and comparative metastasis detection accuracy of 18F-FES PET/CT for ER-Positive breast cancer: Systematic review, meta-analyses and meta-regressions},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  volume = {53},
  number = {4},
  pages = {2815--2829},
  doi = {10.1007/s00259-025-07640-1}
}
Kostenlos starten →